We hypothesized that p53 wild-type acute leukemia cells, known to be highly sensitive to p53-induced apoptosis (22), will be more effectively killed by the M3814 mediated p53 boost in response to calicheamicin-induced DSBs. This evidence concerns the gene TP53 and acute leukemia.